Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Acquired by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC boosted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 8.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 573,037 shares of the medical instruments supplier's stock after buying an additional 43,927 shares during the period. Conestoga Capital Advisors LLC owned 10.55% of Mesa Laboratories worth $75,566,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in shares of Mesa Laboratories by 7.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 131,891 shares of the medical instruments supplier's stock valued at $11,444,000 after acquiring an additional 8,722 shares during the last quarter. Mackenzie Financial Corp purchased a new position in Mesa Laboratories during the 2nd quarter valued at about $596,000. Sanctuary Advisors LLC acquired a new position in Mesa Laboratories in the 2nd quarter valued at about $183,000. SG Americas Securities LLC purchased a new stake in Mesa Laboratories during the third quarter worth about $302,000. Finally, Creative Planning lifted its position in shares of Mesa Laboratories by 100.3% during the third quarter. Creative Planning now owns 5,389 shares of the medical instruments supplier's stock worth $700,000 after purchasing an additional 2,698 shares in the last quarter. 90.60% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Mesa Laboratories from a "buy" rating to a "hold" rating in a research note on Wednesday, November 13th.

Mesa Laboratories Stock Up 2.0 %

NASDAQ:MLAB traded up $2.83 during midday trading on Thursday, reaching $141.73. The company had a trading volume of 49,509 shares, compared to its average volume of 33,080. The stock's fifty day simple moving average is $134.14 and its 200-day simple moving average is $125.77. The company has a current ratio of 0.70, a quick ratio of 0.51 and a debt-to-equity ratio of 0.65. Mesa Laboratories, Inc. has a 12-month low of $83.68 and a 12-month high of $152.75. The firm has a market capitalization of $769.74 million, a price-to-earnings ratio of -3.11 and a beta of 0.83.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%. On average, sell-side analysts anticipate that Mesa Laboratories, Inc. will post 7.39 earnings per share for the current fiscal year.

Mesa Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, February 28th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, February 28th. Mesa Laboratories's dividend payout ratio is presently -1.38%.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.